Everolimus Reduces Angiomyolipoma Volume Journal of the American Academy of Physician Assistants (HealthDay News) – For patients with tuberous sclerosis or sporadic lymphangioleiomyomatosis-associated angiomyolipomata, the angiomyolipoma response rate is significantly higher with everolimus than placebo, with an acceptable safety profile, ... Cancer Drug Controls Tumors in Rare Disorder |
